Oncology

Oncology

Surgery & Therapy

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
41-60 of 63 ARTICLES
https://doi.org/10.12688/f1000research.108827.2
Research Article metrics
Revised
Assessing the anticancer effects of metformin
[version 2; peer review: 1 approved with reservations, 2 not approved]
Peer Reviewers Deqiang Huang; Divya Subramonian; Kasuni H.M. Akalanka
LATEST VERSION PUBLISHED 09 Aug 2022
https://doi.org/10.12688/f1000research.122368.1
Case Report metrics
Case Report: Ovarian fibroma: typical presentation with Meigs’s Syndrome
[version 1; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Irene Iavarone; Bijal Patel; Heera Shenoy
PUBLISHED 22 Jul 2022
https://doi.org/10.12688/f1000research.110320.2
Research Article metrics
Revised
Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy
[version 2; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Shinta Wardani; Hyewon Lee; Smita Kayal
LATEST VERSION PUBLISHED 01 Jul 2022
https://doi.org/10.12688/f1000research.110966.2
Research Article metrics
Revised
Establishment of diagnostic reference level and radiation dose variation in head & neck and pelvis treatment planning in radiation therapy computed tomography
[version 2; peer review: 1 approved]
Peer Reviewers Rekha Reddy Buchapudi
  • Funder
  • Indian Council of Medical Research
LATEST VERSION PUBLISHED 26 May 2022
https://doi.org/10.12688/f1000research.20454.2
Opinion Article metrics
Revised
Time to initiate randomized controlled clinical trials with methadone in cancer patients
[version 2; peer review: 2 approved]
Peer Reviewers Mary Lynn McPherson; Harald Köfeler
LATEST VERSION PUBLISHED 12 May 2022
https://doi.org/10.12688/f1000research.53875.2
Research Article metrics
Revised
Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain
[version 2; peer review: 2 approved]
Peer Reviewers Helena Colom Codina; Philipp Dahm
  • Funder
  • Instituto de Salud Carlos III
LATEST VERSION PUBLISHED 21 Apr 2022
https://doi.org/10.12688/f1000research.110079.1
Research Article metrics
Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania
[version 1; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Divya Subramonian; Sidharth Totadri; Paola Muggeo
PUBLISHED 06 Apr 2022
https://doi.org/10.12688/f1000research.27244.2
Case Report metrics
Revised
Case Report: Good responsiveness of metastatic sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation to immune checkpoint inhibitor after radical surgery and chemotherapy
[version 2; peer review: 2 approved]
Peer Reviewers Wan Song; Katsuhiro Ito
  • Funder
  • National Cancer Center, South Korea
LATEST VERSION PUBLISHED 31 Mar 2022
https://doi.org/10.12688/f1000research.108596.1
Research Article metrics
Diaphragm thickness, mobility and respiratory muscle strength in patients with head and neck cancer receiving chemoradiation therapy: A longitudinal pilot study
[version 1; peer review: 1 approved with reservations, 1 not approved]
Peer Reviewers Asir John Samuel and Vencita Priyanka Aranha; Shane Patman
PUBLISHED 10 Mar 2022
https://doi.org/10.12688/f1000research.108908.1
Systematic Review metrics
Molecular mechanisms of flavonoids and their modulatory effects against breast cancer: A scoping review
[version 1; peer review: 2 approved with reservations, 1 not approved]
Peer Reviewers Muthi Ikawati; Sandip Patel; Nupur Mukherjee
PUBLISHED 09 Mar 2022
https://doi.org/10.12688/f1000research.75870.1
Research Article metrics
Effects of asparaginases and L-carnitine on Western-diet-induced hepatosteatosis in mice
[version 1; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Matías A. Avila; Ruchi Bansal; Olamide B Adelusi
  • Funders
  • This work was supported with a stipend to Mona Ali Mahmoud Assar by the Egyptian cultural affairs and missions’ sector and ministry of higher education
  • European Union and NRW government
PUBLISHED 01 Feb 2022
https://doi.org/10.12688/f1000research.75922.1
Clinical Practice Article metrics PEER REVIEW DISCONTINUED
Thromboembolic events during neoadjuvant chemotherapy in muscle invasive bladder cancer – any correlation to the central venous access? A clinical practice article
[version 1; peer review: 1 approved with reservations]
Peer Reviewers Katsuhiro Ito
PUBLISHED 13 Jan 2022
https://doi.org/10.12688/f1000research.27809.1
Study Protocol metrics
Clinical trial
IMPORTANCE trial: a provisional study-design of a single-center, phase II, double-blinded, placebo-controlled, randomized, 4-week study to compare the efficacy and safety of intranasal esketamine in chronic opioid refractory pain
[version 1; peer review: 2 approved]
Peer Reviewers Vinita Singh; Danny Kupka
PUBLISHED 22 Jan 2021
https://doi.org/10.12688/f1000research.27217.2
Opinion Article metrics
Revised
Cancer T-cell therapy: building the foundation for a cure
[version 2; peer review: 3 approved]
Peer Reviewers John R. James and Muna Fuyal; Barbra J. Sasu; C. Glenn Begley
  • Funder
  • A2 Biotherapeutics, Inc.
LATEST VERSION PUBLISHED 22 Dec 2020
https://doi.org/10.12688/f1000research.27805.2
Study Protocol metrics PEER REVIEW DISCONTINUED
Clinical trial
Revised
The efficacy of acupuncture as a complementary treatment for pain and anxiety after breast cancer surgery: Study protocol for a pragmatic randomized control trial
[version 2; peer review: peer review discontinued]
Peer Reviewers Invited
  • Funder
  • Societat Científica d’Acupuntura, Acadèmia de les Ciències Mèdiques de Catalunya i Balears
LATEST VERSION PUBLISHED 18 Dec 2020
https://doi.org/10.12688/f1000research.20727.2
Research Article metrics
Revised
CCL2 and IL18 expressions may associate with the anti-proliferative effect of noncontact electro capacitive cancer therapy in vivo
[version 2; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Richard Luke Daniels; Yoram Palti; Agung Putra
  • Funders
  • Universitas Gadjah Mada
  • Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia
LATEST VERSION PUBLISHED 23 Jul 2020
https://doi.org/10.12688/f1000research.23455.1
Research Article metrics
Clinical trial
Analgesic efficacy of nefopam for cancer pain: a randomized controlled study
[version 1; peer review: 2 approved]
Peer Reviewers Kok Yuen Ho; Abdul Hadi Mohamed
  • Funder
  • Mahidol University
PUBLISHED 19 May 2020
https://doi.org/10.12688/f1000research.22689.2
Research Article metrics
Revised
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
[version 2; peer review: 3 approved]
Peer Reviewers Jinming Yang; Elena B. Pasquale; Nikki Cheng
  • Funders
  • National Institutes of Health
  • U.S. Department of Veterans Affairs
LATEST VERSION PUBLISHED 14 May 2020
https://doi.org/10.12688/f1000research.20509.2
Opinion Article metrics
Revised
How shall we treat locally advanced triple negative breast cancer?
[version 2; peer review: 2 approved]
Peer Reviewers Brian D. Lehmann; Bruna Cerbelli
LATEST VERSION PUBLISHED 04 May 2020
https://doi.org/10.12688/f1000research.21481.1
Research Article metrics
Effects of ‎tamoxifen on the reproductive system of female breast cancer patients: an ultrasound-based cohort study
[version 1; peer review: 2 not approved]
Peer Reviewers Marian J E Mourits; Lisa Rydén
PUBLISHED 10 Feb 2020
41-60 of 63 ARTICLES
Gateway Areas
Our News
  • Advances in Fibroblast Research launch

    Article collection open for submissions, led by Guest Advisor Dr Matthew Buechler. Submission deadline: 5th October 2023. For more information, contact krishna.sharma@f1000.com.

  • Childhood Cancer launch

    Article collection open for submissions, led by Guest Advisor Dr Ana Banito. Submission deadline: 2nd June 2023. For more information, contact krishna.sharma@f1000.com.

  • Bioinformatics in Cancer Research launch

    Article collection open for submissions, led by Guest Advisors Dr Jacob Luber, Dr Rongling Wu and Dr Li Zhang. Submission deadline: 30th November 2022. For more information, contact vinitha.raghavan@f1000.com.

  • Equitable Cancer Care launch

    Article collection open for submissions, led by Guest Advisor Dr. Matthew Schabath. For more information, contact krishna.sharma@f1000.com.

  • Radiomics launch

    Article collection open for submission, led by Guest Advisor Dr Alberto Traverso. For more information, contact krishna.sharma@f1000.com.

Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.